-
Industry Symposium 1
Navigating the Course of Advanced Ovarian Cancer Maintenance Therapy with Current and Emerging Biomarkers
organised by GSK
Thursday, February 26, 2026 │ 12:30 – 13:30

-
Industry Symposium 2
Optimizing Management in PROC: From Early Diagnosis to Strategic and targeted Treatment Sequencing
organised by AbbVieThursday, February 26, 2026 │12:30 – 13:30

-
Industry Symposium 3
Shaping the Future of Endometrial Cancer Management: Clinical Strategies and Study Updates
organised by MSD
Friday, February 27, 2026 │ 11:00 – 12:00

-
Industry Symposium 4
PARP Inhibitors in advanced Ovarian Cancer.
Expanding Horizons: Transforming Outcomes and Supporting Patients to Move Forwardorganised by pharma&
Friday, February 27, 2026 │ 11:00 – 12:00

-
Industry Symposium 5
Evolving Strategies in Platinum-Resistant Ovarian Cancer: Bridging Evidence, Regulation, and Clinical Care
organised by GOG/Corcept Therapeutics
Friday, February 27, 2026 │ 13:50 – 14:50

-
Industry Symposium 6
From Diagnosis to Decision: Endometrial Cancer Through the Clinical Lens
organised by AstraZeneca
Saturday, February 28, 2026 │ 11:30 – 12:30

-